AAAAAA

   
Results: 1-17 |
Results: 17
Prospects for an SV40 vaccine
Authors: Imperiale, MJ Pass, HI Sanda, MG
Citation: Mj. Imperiale et al., Prospects for an SV40 vaccine, SEM CANC B, 11(1), 2001, pp. 81-85
Mxil, a Myc antagonist, suppresses proliferation of DU145 human prostate cells
Authors: Taj, MM Tawil, RJ Engstrom, LD Zeng, Z Hwang, C Sanda, MG Wechsler, DS
Citation: Mm. Taj et al., Mxil, a Myc antagonist, suppresses proliferation of DU145 human prostate cells, PROSTATE, 47(3), 2001, pp. 194-204
Assessment of early continence recovery after radical prostatectomy: Patient reported symptoms and impairment
Authors: Kielb, S Dunn, RL Rashid, MG Murray, S Sanda, MG Montie, JE Wei, JT
Citation: S. Kielb et al., Assessment of early continence recovery after radical prostatectomy: Patient reported symptoms and impairment, J UROL, 166(3), 2001, pp. 958-961
Functional p53 mutation as a molecular determinant of paclitaxel and gemcitabine susceptibility in human bladder cancer
Authors: Kielb, SJ Shah, NL Rubin, MA Sanda, MG
Citation: Sj. Kielb et al., Functional p53 mutation as a molecular determinant of paclitaxel and gemcitabine susceptibility in human bladder cancer, J UROL, 166(2), 2001, pp. 482-487
Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate
Authors: Rashid, MG Sanda, MG Vallorosi, CJ Rios-Doria, J Rubin, MA Day, ML
Citation: Mg. Rashid et al., Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate, CANCER RES, 61(2), 2001, pp. 489-492
Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development
Authors: Charles, LG Xie, YC Restifo, NP Roessler, B Sanda, MG
Citation: Lg. Charles et al., Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development, WORLD J URO, 18(2), 2000, pp. 136-142
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
Authors: Nelson, WG Simons, JW Mikhak, B Chang, JF DeMarzo, AM Carducci, MA Kim, M Weber, CE Baccala, AA Goeman, MA Clift, SM Ando, DG Levitsky, HI Cohen, LK Sanda, MG Mulligan, RC Partin, AW Carter, HB Piantadosi, S Marshall, FF
Citation: Wg. Nelson et al., Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies, CANC CHEMOT, 46, 2000, pp. S67-S72
Development and validation of the expanded prostate cancer index composite(EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
Authors: Wei, JT Dunn, RL Litwin, MS Sandler, HM Sanda, MG
Citation: Jt. Wei et al., Development and validation of the expanded prostate cancer index composite(EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer, UROLOGY, 56(6), 2000, pp. 899-905
Benign prostatic glands at surgical margins of radical prostatectomy specimens: Frequency and associated risk factors
Authors: Shah, R Bassily, N Wei, J Mucci, NR Montie, JE Sanda, MG Rubin, MA
Citation: R. Shah et al., Benign prostatic glands at surgical margins of radical prostatectomy specimens: Frequency and associated risk factors, UROLOGY, 56(5), 2000, pp. 721-725
Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer
Authors: Marcovich, R Wojno, KJ Wei, JT Rubin, MA Montie, JE Sanda, MG
Citation: R. Marcovich et al., Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer, UROLOGY, 55(6), 2000, pp. 904-908
Prospective assessment of patient reported urinary continence after radical prostatectomy
Authors: Wei, JT Dunn, RL Marcovich, R Montie, JE Sanda, MG
Citation: Jt. Wei et al., Prospective assessment of patient reported urinary continence after radical prostatectomy, J UROL, 164(3), 2000, pp. 744-747
Collagen injection for the treatment of incontinence after cystectomy and orthotopic neobladder reconstruction in women
Authors: Tchetgen, MB Sanda, MG Montie, JE Faerber, GJ
Citation: Mb. Tchetgen et al., Collagen injection for the treatment of incontinence after cystectomy and orthotopic neobladder reconstruction in women, J UROL, 163(1), 2000, pp. 212-214
Gene therapy - Practice and promise
Authors: Rashid, MG Sanda, MG
Citation: Mg. Rashid et Mg. Sanda, Gene therapy - Practice and promise, CURR CLIN U, 2000, pp. 317-336
Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen
Authors: Xie, YC Hwang, C Overwijk, W Zeng, Z Eng, MH Mule, JJ Imperiale, MJ Restifo, NP Sanda, MG
Citation: Yc. Xie et al., Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen, J NAT CANC, 91(2), 1999, pp. 169-175
Early castration reduces prostatic carcinogenesis in transgenic mice
Authors: Eng, MH Charles, LG Ross, BD Chrisp, CE Pienta, KJ Greenberg, NM Hsu, CX Sanda, MG
Citation: Mh. Eng et al., Early castration reduces prostatic carcinogenesis in transgenic mice, UROLOGY, 54(6), 1999, pp. 1112-1119
Recombinant vaccinia-PSA [PROSTVAC] can induce a prostate-specific immune response in androgen-modulated human prostate cancer
Authors: Sanda, MG Smith, DC Charles, LG Hwang, C Pienta, KJ Schlom, J Milenic, D Panicali, D Montie, JE
Citation: Mg. Sanda et al., Recombinant vaccinia-PSA [PROSTVAC] can induce a prostate-specific immune response in androgen-modulated human prostate cancer, UROLOGY, 53(2), 1999, pp. 260-266
Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
Authors: Simons, JW Mikhak, B Chang, JF DeMarzo, AM Carducci, MA Lim, M Weber, CE Baccala, AA Goemann, MA Clift, SM Ando, DG Levitsky, HI Cohen, LK Sanda, MG Mulligan, RC Partin, AW Carter, HB Piantadosi, S Marshall, FF Nelson, WG
Citation: Jw. Simons et al., Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer, CANCER RES, 59(20), 1999, pp. 5160-5168
Risultati: 1-17 |